Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Biomacromolecules
|
March 24, 2016
A Nanoparticle Platform To Evaluate Bioconjugation and Receptor-Mediated Cell Uptake Using Cross-Linked Polyion Complex Micelles Bearing Antibody Fragments
Stelios Florinas, Marc Liu, Ryan Fleming, et al.
Mabs
|
March 6, 2019
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Jason B White, Ryan Fleming, Luke Masterson, et al.
Cancer Research
|
November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo
Dowdy Jackson, John Gooya, Shenlan Mao, et al.
Cancer Research
|
March 12, 2017
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies
Jonathan Rios-Doria, Jay Harper, Raymond Rothstein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 22, 2016
Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics
Pamela Thompson, Ryan Fleming, Binyam Bezabeh, et al.
Science Translational Medicine
|
November 14, 2014
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
Antonio DiGiandomenico, Ashley E Keller, Cuihua Gao, et al.
Molecular Cancer Therapeutics
|
May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Leukemia
|
October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells
Krista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 24, 2025
Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine Response
Johannes Wedel, Ying Tang, Bayan Alsairafi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Biomacromolecules
|
March 24, 2016
A Nanoparticle Platform To Evaluate Bioconjugation and Receptor-Mediated Cell Uptake Using Cross-Linked Polyion Complex Micelles Bearing Antibody Fragments
Stelios Florinas, Marc Liu, Ryan Fleming, et al.
Mabs
|
March 6, 2019
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer
Jason B White, Ryan Fleming, Luke Masterson, et al.
Cancer Research
|
November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo
Dowdy Jackson, John Gooya, Shenlan Mao, et al.
Cancer Research
|
March 12, 2017
Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies
Jonathan Rios-Doria, Jay Harper, Raymond Rothstein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 22, 2016
Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics
Pamela Thompson, Ryan Fleming, Binyam Bezabeh, et al.
Science Translational Medicine
|
November 14, 2014
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
Antonio DiGiandomenico, Ashley E Keller, Cuihua Gao, et al.
Molecular Cancer Therapeutics
|
May 15, 2020
Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells
Ruoyan Chen, Saravanan Rajan, Michael G Overstreet, et al.
Leukemia
|
October 14, 2018
Preclinical assessment of an antibody-PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells
Krista Kinneer, Matt Flynn, Suneetha B Thomas, et al.
Molecular Cancer Therapeutics
|
March 3, 2021
Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR
Shenlan Mao, Raghothama Chaerkady, Wen Yu, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
December 24, 2025
Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine Response
Johannes Wedel, Ying Tang, Bayan Alsairafi, et al.
Page
of 4